Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (221-230 of 329) with videos related to

Pageof 33
Sort By:
The European Respiratory Journal|May 24, 2020
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trialArmelle Lavole, Laurent Greillier, Julien Mazières, et al.
Medicine|March 14, 2009
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patientsMatthieu Mahévas, Francois Xavier Lescure, Jean-Jacques Boffa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancersAnne Mc Leer, Matthieu Foll, Marie Brevet, et al.
Chest|February 25, 2016
CT Imaging Assessment of Response to Treatment in Chronic Pulmonary AspergillosisCendrine Godet, François Laurent, Anne Bergeron, et al.
BMJ Open|December 29, 2017
Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in FranceSylvie Leroy, Jonathan Benzaquen, Andrea Mazzetta, et al.
Autoimmunity Reviews|June 15, 2020
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicitiesYves Allenbach, Céline Anquetil, Ali Manouchehri, et al.
The European Respiratory Journal|March 7, 2015
No impact of passive smoke on the somatic profile of lung cancers in never-smokersSébastien Couraud, Didier Debieuvre, Lionel Moreau, et al.
International Journal of Cancer|January 6, 2011
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH studyEmilie Lanoy, Jean-Philippe Spano, Fabrice Bonnet, et al.
Advances in Therapy|November 10, 2021
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD CohortVincent Cottin, Sonia Guéguen, Hilario Nunes, et al.
Cancers|April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive PatientsValérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Pageof 33

Showing results (221-230 of 329) with videos related to

Sort By:
Pageof 33
The European Respiratory Journal|May 24, 2020
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trialArmelle Lavole, Laurent Greillier, Julien Mazières, et al.
Medicine|March 14, 2009
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patientsMatthieu Mahévas, Francois Xavier Lescure, Jean-Jacques Boffa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancersAnne Mc Leer, Matthieu Foll, Marie Brevet, et al.
Chest|February 25, 2016
CT Imaging Assessment of Response to Treatment in Chronic Pulmonary AspergillosisCendrine Godet, François Laurent, Anne Bergeron, et al.
BMJ Open|December 29, 2017
Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in FranceSylvie Leroy, Jonathan Benzaquen, Andrea Mazzetta, et al.
Autoimmunity Reviews|June 15, 2020
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicitiesYves Allenbach, Céline Anquetil, Ali Manouchehri, et al.
The European Respiratory Journal|March 7, 2015
No impact of passive smoke on the somatic profile of lung cancers in never-smokersSébastien Couraud, Didier Debieuvre, Lionel Moreau, et al.
International Journal of Cancer|January 6, 2011
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH studyEmilie Lanoy, Jean-Philippe Spano, Fabrice Bonnet, et al.
Advances in Therapy|November 10, 2021
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD CohortVincent Cottin, Sonia Guéguen, Hilario Nunes, et al.
Cancers|April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive PatientsValérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Pageof 33